PTC THERAPEUTICS, INC.
Ticker: 1070081
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 357.81-0.8% | 360.52+32.3% | 272.55+29.2% | 211.01+18.0% | 178.88-84.8% | 1.2K+497.6% | 196.79+5.4% | 186.70 |
| Total Income | 357.81-0.8% | 360.52+32.3% | 272.55+29.2% | 211.01+18.0% | 178.88-84.8% | 1.2K+497.6% | 196.79+5.4% | 186.70 |
| EXPENSES | ||||||||
| Expenditure | 332.69+57.3% | 211.54-7.1% | 227.59+9.4% | 207.99-2.7% | 213.83+3.9% | 205.87-18.1% | 251.30+10.7% | 226.92 |
| Tax | 10.61-24.5% | 14.05+3914.3% | 0.35+100.9% | -38.97-528.5% | -6.20-109.8% | 63.27+630.6% | 8.66-35.6% | 13.45 |
| PROFIT | ||||||||
| PBT | -41.09-142.1% | 97.55+4065.4% | -2.46+89.3% | -23.07+67.5% | -71.05-107.6% | 929.83+1048.9% | -97.99-14.3% | -85.73 |
| Net Profit | -51.69-161.9% | 83.50+3071.5% | -2.81-117.7% | 15.90+124.5% | -64.85-107.5% | 866.56+912.5% | -106.65-7.5% | -99.18 |
| KEY METRICS | ||||||||
| OPM % | 7.02%-34.30pp | 41.32%+24.83pp | 16.50%+15.07pp | 1.43%+20.97pp | -19.54%-102.04pp | 82.50%+110.20pp | -27.70%-6.16pp | -21.54% |
| NPM % | -14.45%-37.61pp | 23.16%+24.19pp | -1.03%-8.56pp | 7.53%+43.79pp | -36.25%-109.94pp | 73.68%+127.88pp | -54.20%-1.08pp | -53.12% |
| EPS | -0.62-161.4% | 1.01+3466.7% | -0.03-115.0% | 0.20+124.1% | -0.83-107.5% | 11.09+897.8% | -1.39-7.8% | -1.29 |
Corporate Events
Board MeetingPTCT
202630Jul
Board Meeting
Second Quarter 2026 Financial Results and Corporate Update C…
SEC Filing ↗ Board MeetingPTCT
20268Jun
Board Meeting
Director Resignation and Consulting Agreement — Alethia Youn…
SEC Filing ↗ Board MeetingPTCT
20262Jun
Board Meeting
Annual Meeting of Stockholders to elect Class I directors, r…
SEC Filing ↗